White label video solution
Trainable AI Chatbot
White label messaging app
White label telehealth
AI medical assistant
Tools to build your own HIPAA telehealth app
Secure hosting with encryption and BAA
QuickBlox Discord
Community
A white-label telehealth evaluation checklist is a structured framework used to assess vendors across branding, workflows, integrations, compliance, AI, and scalability before signing a contract.
In simple terms, this checklist gives B2B healthcare buyers a practical framework for comparing white-label telehealth vendors against the criteria that matter most in production — not just the ones that appear in a demo.
QuickBlox builds the communication infrastructure behind white-label telehealth deployments — video, messaging, AI, and HIPAA-compliant hosting that healthcare organizations brand and operate as their own. The criteria on this page reflect what we have seen determine deployment success across real healthcare organizations.
This checklist is designed for healthcare providers, digital health startups, and product teams evaluating white-label telehealth platforms prior to procurement.
Work through each section before reaching contract stage with any vendor. For every item, the goal is a documented answer — not a verbal assurance. Where a vendor cannot provide a clear response, note it explicitly and follow up in writing before proceeding.
For a detailed explanation of why each criterion matters in production, see What Are the Key Features of White-Label Telehealth Platforms? — this checklist is designed to be used alongside that guide as an active procurement tool.
Can the platform be fully rebranded with no visible vendor footprint?
Ask for: A live demonstration of the complete patient journey under a test brand.
Does the platform adapt to your clinical workflows — and will the vendor map it against your specific needs before you sign?
Ask for: A written discovery summary identifying platform fit, configuration requirements, custom development needs, and gaps against your stated requirements — including a workflow demonstration covering the full patient journey from intake to post-visit follow-up.
Has integration been validated against your specific systems — not just claimed in general terms?
Ask for: A validated integration list specifying tested live deployments — and the process for systems outside that list.
Are compliance, data ownership, and breach response each covered — separately and completely?
Ask for: The BAA itself, plus written confirmation of which system components are covered under it.
See also What is HIPAA-Compliance and What Makes a Telehealth Platform HIPAA-Compliant? for a detailed overview of what is required.
Ask for: Written confirmation of data ownership, export format and timeline, and post-termination deletion policy — before contract stage.
Ask for: The vendor’s incident response policy and breach notification procedure in full.
Is AI native to the platform — and are clinical safety guardrails documented?
Ask for: Written confirmation of AI architecture — native or integrated — and clinical safety guardrails documentation.
What happens when the platform doesn’t cover everything you need?
Ask for: Written roadmap documentation with clear production, beta, and roadmap status for all evaluated features.
Does the pricing model remain predictable and proportionate as your organization grows?
Ask for: A written commercial model covering current pricing, scale pricing, and renewal terms before the initial contract is agreed.
The organizations that navigate white-label telehealth procurement most successfully treat this checklist as the starting point of a vendor conversation — not a box-ticking exercise at the end of one. The items most likely to go undocumented before contract stage are precisely the ones that determine what happens six months after deployment begins.
Q-Consultation is QuickBlox’s white-label telehealth platform. We are happy to work through this checklist directly — providing written responses to each criterion, conducting structured discovery against your specific workflows, and producing the documentation listed above before you reach contract stage. If a requirement falls outside our current platform capabilities, we will tell you during discovery.
Book a demo or speak to our team about your specific requirements.
Workflow customization — specifically whether the platform adapts to your clinical workflows or requires your organization to adapt to it. This is rarely visible in a standard demo and should be established through structured vendor discovery before contract stage.
Ask directly: is this capability built into your platform architecture, or does it depend on a third-party vendor? Follow up by asking which AI components are covered under the platform BAA. Native AI will have a single clear answer.
Establish in writing: who owns the patient data, in what format it can be exported, the timeline for export following contract termination, and whether the vendor uses any patient or session data for purposes beyond direct service delivery — including AI model training or product
At minimum: a signed BAA covering all system components, written confirmation of data ownership and export terms, a validated integration list, a written discovery summary, current roadmap documentation with clear status labelling, and a commercial model covering scale pricing and renewal terms.
Early — ideally before the final evaluation stage. A vendor confident in their compliance posture will have no reason to delay. A BAA that appears for the first time at contract stage is a signal worth noting.
Last reviewed: March 2026
Written by: Gail M.
Reviewed by: QuickBlox Product & Platform Team